Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
Daily Oncology News
Adding Radiotherapy to Chemotherapy Boosts Survival in Nasopharyngeal Carcinoma
Patients treated with chemotherapy plus radiotherapy had a 64% reduced likelihood of disease progression or death compared with those who underwent chemotherapy alone.
A 6-Gene Expression Signature May Predict Benefit From Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer
The purpose of this study was to develop and test a gene-expression profiling assay to facilitate patient selection for induction chemotherapy in the setting of LA-NPC.
Study Finds Patients With Rare Ovarian Cancer Develop Chemoresistance
Patients with low-grade serous carcinoma of the ovary or peritoneum (LGSC) developed chemoresistance to neoadjuvant platinum-based therapy.
Improving Diagnosis and Staging Times for Patients With Suspected Lung Cancer
Standardized triage process significantly improved timeliness of diagnosis and staging of suspected lung cancer at a rapid assessment clinic.
Shorter PSA Doubling Time Predicts Worse Outcomes in nmCRPC
In men with nonmetastatic castration-resistant prostate cancer, a PSA doubling time of less than 3 months vs 15 months or more increases the risk of metastasis, which in turn is associated with a large increase in healthcare utilization and costs.
MRI Useful for Diagnosing Muscle-Invasive Bladder Cancer
Multiparametric magnetic resonance imaging is highly accurate in differentiating nonmuscle-invasive from muscle-invasive bladder cancer, according to a new systematic review and meta-analysis.
COVID-19 Case Fatality Rate 29 Percent in Multiple Myeloma Patients
Increased odds of adverse outcomes seen for Hispanic/Latinos, African-American Blacks versus white patients.
Systemic Antibacterial Prophylaxis Not Recommended in All Pediatric Intensive Chemotherapy or HSCT
These guidelines were developed to facilitate decision-making regarding use of SAP in pediatric patients with cancer and children undergoing HSCT.
Patients’ Expectations of Palliative Chemotherapy Unchanged by Educational Intervention
The effectiveness of using an educational video and booklet to improve patients’ expectations of cure from palliative chemotherapy was investigated in this study.
Fertility Preservation Counseling Before Chemotherapy May Be Infrequent
Clinicians are more likely to counsel younger and female patients on reproductive risks before initiating chemotherapy, despite available ASCO guidelines.
Pregnancy After BRCA-Mutated Breast Cancer Deemed Safe
Pregnancy was not linked to differences in survival outcomes.
COVID-19 Vaccine Candidate Provides Protection in Animal Challenge Study
Vaccination with mRNA-1273, Moderna’s coronavirus disease 2019 (COVID-19) vaccine candidate, led to robust immune responses and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates.
Sorafenib Maintenance Therapy After Allo-HSCT Improves Outcomes in FLT3-ITD–Positive AML
Among patients with FLT3-internal tandem repeats, sorafenib maintenance therapy reduces the risk of relapse and death after allo-HSCT.
New Evidence Supports Update of ASCO Guidelines on Prevention, Treatment of CIPN
A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.
Skin Cancer Clinical Trials
Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy
Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy
Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC
Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC
Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Daily Oncology News
